CASR and asthma: Recently it has also been suggested that calcilytics could be repurposed for treating asthma, as upregulated CaSR-signalling has been shown to mediate increased airway hyperresponsiveness in an asthmatic mouse model and in human lung tissue isolated from asthmatic patients (Yarova et al., 2015).